Origin and Classification
Cardiac glycosides are derived from medicinal plants. Modern medical practice utilizes preparations extracted from three main groups:
- Foxglove glycosides (Digitalis) — include digoxin, acetyldigoxin B, and lanatoside C.
- Strophanthus glycosides (Strophanthus) — represented by ouabain (strophanthin G).
- Lily of the valley glycosides (Convallaria) — contain corglycone and convallatoxin.
Digitoxin and older lily of the valley preparations are largely obsolete in modern therapeutics.
Molecular Mechanism of Action
The therapeutic action is based on altering ion transport across the sarcolemma of cardiomyocytes.
- Target: Inhibition of the $Na^+,K^+$-ATPase pump enzyme.
- Ionic Shifts: Failure to extrude sodium leads to intracellular sodium accumulation and a decrease in intracellular potassium.
- Calcium Cascade: Elevated intracellular sodium impairs the $Na^+/Ca^{2+}$ exchanger, reducing calcium extrusion and increasing cytosolic calcium concentration.
Excess calcium is sequestered into the sarcoplasmic reticulum and released upon excitation, producing a powerful myocardial contraction.
Primary Pharmacological Effects
The effects of cardiac glycosides on the heart are classically divided into four main properties:
- Positive inotropic effect: Increased force and shortened duration of systole.
- Negative chronotropic effect: Decreased heart rate (bradycardia) and prolonged diastole, promoting an energy-efficient cardiac cycle.
- Negative dromotropic effect: Slower conduction velocity through the atrioventricular (AV) node.
- Positive bathmotropic effect: Increased myocardial excitability (at lower doses).
Reduced heart rate and conduction velocity are largely mediated by vagotonia (increased vagal tone).
Clinical Use and Adverse Effects
Cardiac glycosides are prescribed for acute and chronic heart failure, as well as for rate control in atrial fibrillation with rapid ventricular response.
The choice of agent depends on the desired onset of action:
- Ouabain is administered exclusively intravenously for acute conditions (onset within 2–10 minutes).
- Digoxin is versatile: given intravenously for acute heart failure and orally for chronic maintenance.
Overdose causes dangerous rhythm and conduction disturbances (ventricular extrasystoles, AV blocks), as well as extracardiac symptoms such as gastrointestinal distress, xanthopsia (yellow-green vision), and neurological disturbances.